Stay updated on Mepolizumab in Severe Asthma: Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.

Latest updates to the Mepolizumab in Severe Asthma: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.6.5 appears on the page, replacing the previous v3.6.4. This indicates an internal update to the page while the study details remain unchanged.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a new revision label v3.6.4 replacing the previous v3.6.3. This indicates a version update to the page metadata without visible changes to study content in the provided diffs.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, representing a maintenance update to the study page. There is no indication of changes to the study data or displayed content.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status notice. The Intervention/Treatment heading was standardized and the revision identifier updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check73 days agoChange DetectedThe page's revision label in the footer was updated from v3.5.4 to v3.5.5, signaling a small site update.SummaryDifference0.0%

- Check95 days agoChange DetectedA new publication citation about cost-effectiveness of mepolizumab in Chinese patients with severe asthma was added to Publications, and the page revision was updated from v3.5.3 to v3.5.4.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab in Severe Asthma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.